中文

日科化学 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-21

日科化学 reported revenue of ¥1.91B for the period ended 2026-06-30, -2.6% year on year. Net income was ¥0.03B, a 1.8% net margin on a 7.8% gross margin. The largest revenue line is ACM系列产品 at 40% of the total. Free cash flow for the period was ¥0.06B.

ItemAmountY/Y
Revenue¥1.91B-2.6%
Gross profit¥0.15B
Operating income¥0.05B
Net income¥0.03B
Gross margin7.8%Net margin 1.8%
Revenue Q/Q+8.7%

Revenue Segments

SegmentRevenueShare
ACM系列产品¥0.77B40.3%
ACR系列产品¥0.76B40.0%
氯碱类产品¥0.23B11.8%
算力服务¥0.12B6.1%
其他(补充)¥0.03B1.7%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥1.76B92.2%
R&D¥0.02B0.8%
SG&A¥0.06B3.3%
Tax & other¥0.01B0.6%

Balance sheet & cash flow

ItemAmount
Total assets¥5.04B
Total liabilities¥2.51B
Shareholders' equity¥2.53B
Equity / assets50.1%
Operating cash flow¥0.07B
Capital expenditure¥0.02B
Free cash flow¥0.06B
Cash conversion (OCF / net income)223%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

电科院东方电热安利股份鸿利智汇金运激光银禧科技科大智能北京君正正海磁材金力泰上海钢联光韵达

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies